Respiratory Infections News

In less than a year from the emergence of SARS-CoV-2, several safe and effective COVID-19 vaccines were created and authorized for use in the United States and globally.

When scientists began working on solutions for the COVID-19 pandemic in early 2020, it seemed unlikely that a safe and effective vaccine would be available in a year, according to Paul A. Offit, MD.

As early as I can remember, science, history and fiction captured my interest.

A study of COVID-19 vaccine responses among kidney transplant recipients in Israel suggested that they may remain at high risk for COVID-19 even after vaccination, according to results published in The American Journal of Transplantation.

Study results have shown that individuals experiencing homelessness are particularly vulnerable to COVID-19 and face heightened transmission risks in shelters.

European regulators said Tuesday that a warning about unusual blood clots with low blood platelets should be added to information about the Johnson & Johnson COVID-19 vaccine but also that the benefits of the vaccine outweigh the risks.

Women vaccinated against COVID-19 produced “robust” levels of anti-SARS-CoV-2-specific antibodies in breast milk samples for 6 weeks after vaccination, according to a study of dozens of breastfeeding women in Israel.

None of the 43 traditional antibiotics in the clinical pipeline that target WHO priority pathogens, Clostridioides difficile or tuberculosis sufficiently addresses drug resistance, according to a new report.

COVID-19 racial and ethnic disparities among young people, which were “substantial” early in the pandemic, decreased over time last year, mostly because of an increase in cases among white people, researchers reported in MMWR.

An Iowa hospital’s infection prevention and control program experienced a 500% increase in call volume last year — an under-evaluated impact of the COVID-19 pandemic, researchers said at the SHEA Spring Conference.